Publication Beamlines Strategic Pillar
Flath, Benjamin (2012). Structural characterization of the type II secretion system of Aeromonas hydrophila. Supervisor: Grochulski, Pawel; Howard, Peter. Saskatchewan, Canada: University of Saskatchewan. http://hdl.handle.net/10388/ETD-2012-04-909. CMCF-ID Health
Protsko, Carla (2012). Structural analysis of UDP-N-acetylgalactopyranose mutase from Campylobacter jejuni 11168. Supervisor: Sanders, David A.. Saskatchewan, Canada: Biochemistry, University of Saskatchewan. http://hdl.handle.net/10388/ETD-2012-11-806. CMCF-ID Health
Khan, Muhammad Qasim (2010). Misfolding of particular PrP species and susceptibility to prion infection. Supervisor: Chakrabartty, Avijit . Ontario, Canada: University of Toronto. http://hdl.handle.net/1807/24589. CMCF-ID Health
Krska, Daniel (2014). Larvin: The characterization of a novel mono-ADP-ribosyltransferase toxin. Supervisor: Merrill, Rod. Ontario, Canada: The University of Guelph. http://hdl.handle.net/10214/8117. CMCF-ID Health
Ivanochko, Danton; Miura, Kazutoyo; Hailemariam, Sophia; Ravichandran, Rashmi; Song, Yiting et al. (2026). A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activity. Nature Communications . 10.1038/s41467-026-68761-1. CMCF-ID Health
Haines, Eric; Burke, Michael; Catterall, Rachel; De Jesus, Victor; Hidalgo, Daniel et al. (2026). The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers. Nature Cancer . 10.1038/s43018-025-01081-3. [PDB: 9ecu] CMCF-ID Health
Kwon, Min Chul; Thuring, Jan Willem; Querolle, Olivier; Dai, Xuedong; Verhulst, Tinne et al. (2024). Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias. Blood 144(11) , 1206-1220. 10.1182/blood.2023022480. [PDB: 9z4x] CMCF-ID Health
Kimani, Serah W.; Noureldin, Mahmoud; Wilson, Brian; Hoffer, Laurent; Green, Stuart R. et al. (2025). OICR-41103 as a chemical probe for the DCAF1 WD40 domain. Communications Biology 8(1) . 10.1038/s42003-025-08491-0. [PDB: 9yv4] CMCF-ID Health
Wang, Mingyu; Du, Grace; Yongo‐Luwawa, Charity; Lu, Angelina; Kinrade, Brett et al. (2025). Peptide‐based ligand antagonists block a Vibrio cholerae adhesin. FEBS Letters . 10.1002/1873-3468.70231. [PDB: 9y9w, 9ybq] CMCF-ID Health
Luo, Chuanyun; Paetzel, Mark (2025). Crystal structure of Escherichia coli type I signal peptidase P84A in complex with lipopeptide antibiotic arylomycin A2. Journal of Structural Biology 217(4) , 108260. 10.1016/j.jsb.2025.108260. [PDB: 9nlo] CMCF-ID Health
Ereño-Orbea, June; Pang, Lijuan; Sicard, Taylor; Nycholat, Corwin; Cui, Hong et al. (2025). Molecular Insights into the Engagement of High-Affinity Sialylated Ligands to Human CD22. JACS Au . 10.1021/jacsau.5c01013. [PDB: 9rm3, 9ro7, 9rob] CMCF-BM, CMCF-ID Health
Bekkering, Ezra T.; Yoo, Randy; Hailemariam, Sophia; Heide, Fabian; Ivanochko, Danton et al. (2025). Cryo-EM structure of endogenous Pfs230:Pfs48/45 complex with six antibodies reveals mechanisms of malaria transmission-blocking activity. Immunity . 10.1016/j.immuni.2025.09.014. [PDB: 9n7k] CMCF-ID Health
Legare, Scott; Heide, Fabian; Gabir, Haben; Rafiei, Faride; Meier, Markus et al. (2024). Identifying the molecular basis of Laminin N-terminal domain Ca2+ binding using a hybrid approach. Biophysical Journal 123(16) , 2422-2430. 10.1016/j.bpj.2024.06.005. CMCF-ID Health
Heide, Fabian; McDougall, Matthew; Harder-Viddal, Candice; Roshko, Roy; Davidson, David et al. (2021). Boron rich nanotube drug carrier system is suited for boron neutron capture therapy. Scientific Reports 11(1) . 10.1038/s41598-021-95044-0. CMCF, CMCF-ID Health
Hemmings, Mark; Zieliński, Michał; Golkar, Tolou; Blanchet, Jonathan; Pistofidis, Angelos et al. (2025). Enzyme-mediated aminoglycoside resistance without target mimicry. Communications Chemistry 8(1) . 10.1038/s42004-025-01666-0. [PDB: 9mgu] CMCF-ID Health